University Hospital of North Norway, Harstad
Welcome,         Profile    Billing    Logout  
 6 Trials 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Goll, Rasmus
NCT04691544: Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome

Active, not recruiting
3
450
Europe
Fecal microbiota transplantation (FMT)
University Hospital of North Norway, Oslo University Hospital, Sorlandet Hospital HF, Haukeland University Hospital, Alesund Hospital
Irritable Bowel Syndrome
09/23
12/26
COLONIZE, NCT03796650 / 2018-004580-31: Fecal Transplantation for Primary Clostridium Difficile Infection

Terminated
3
104
Europe
Fecal microbiota transplantation, FMT, IMT, Bacteriotherapy, Vancomycin
Oslo University Hospital, South-Eastern Norway Regional Health Authority, University Hospital of North Norway, Haukeland University Hospital, Helse Nord-Trøndelag HF, Vestre Viken Hospital Trust, The Hospital of Vestfold, Sykehuset Telemark, Alesund Hospital, University Hospital, Akershus, Lovisenberg Diakonale Hospital, Sorlandet Hospital HF, Ostfold Hospital Trust, Diakonhjemmet Hospital, Nordlandssykehuset HF, Sykehuset Innlandet HF, Helse Stavanger HF
Clostridium Difficile Infection
04/24
04/24
NCT03691987: The Comeback Study

Completed
2
80
Europe
Preprocessed thawed donor FMT, Preprocessed thawed autologous FMT
University Hospital of North Norway, The Research Council of Norway, Quadram Institute Bioscience, Umeå University, Cornell University
Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
03/23
12/23
NCT06233461: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Recruiting
2
268
Europe, Canada, Japan, US, RoW
TAK-279, Zasocitinib, Placebo
Takeda
Crohn's Disease
09/26
07/27
NCT06254950: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

Recruiting
2
207
Europe, Canada, Japan, US, RoW
TAK-279, Zasocitinib, Placebo
Takeda
Ulcerative Colitis
09/26
08/27
NCT05660109 / 2022-001656-41: A Study to Assess the Safety of TPM502 in Adults With Celiac Disease

Completed
2
38
Europe, RoW
TPM502, Placebo
Topas Therapeutics GmbH, Topas Therapeutics GmbH
Celiac Disease
07/24
07/24
Johnsen, Peter H
NCT04691544: Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome

Active, not recruiting
3
450
Europe
Fecal microbiota transplantation (FMT)
University Hospital of North Norway, Oslo University Hospital, Sorlandet Hospital HF, Haukeland University Hospital, Alesund Hospital
Irritable Bowel Syndrome
09/23
12/26
COLONIZE, NCT03796650 / 2018-004580-31: Fecal Transplantation for Primary Clostridium Difficile Infection

Terminated
3
104
Europe
Fecal microbiota transplantation, FMT, IMT, Bacteriotherapy, Vancomycin
Oslo University Hospital, South-Eastern Norway Regional Health Authority, University Hospital of North Norway, Haukeland University Hospital, Helse Nord-Trøndelag HF, Vestre Viken Hospital Trust, The Hospital of Vestfold, Sykehuset Telemark, Alesund Hospital, University Hospital, Akershus, Lovisenberg Diakonale Hospital, Sorlandet Hospital HF, Ostfold Hospital Trust, Diakonhjemmet Hospital, Nordlandssykehuset HF, Sykehuset Innlandet HF, Helse Stavanger HF
Clostridium Difficile Infection
04/24
04/24
Fjellstad, Maria
TWIST, NCT03181360 / 2014-000096-80: Tenecteplase in Wake-up Ischaemic Stroke Trial

Recruiting
3
600
Europe, US, RoW
Tenecteplase, Metalyse, Control
University Hospital of North Norway, UiT The Arctic University of Norway, The Royal Norwegian Ministry of Health, Norwegian Health Association
Ischemic Stroke, Stroke, Acute
12/21
12/22
RCTFMTobesity, NCT03273855: Randomized Controlled Trial of Fecal Microbiota Transplantation in Severe Obesity

Enrolling by invitation
N/A
60
Europe
Fecal microbiota transplantation, Placebo: fecal microbiota transplantation
University Hospital of North Norway, Norwegian University of Science and Technology, Lovisenberg Diakonale Hospital, Nordlandssykehuset HF, Helse Nord, University of Tromso, Norwegian University of Life Sciences, University of Oslo
Obesity, Morbid
05/23
05/23
Skjevling, Linn Kallbekken
No trials found

Download Options